Market Tracker

09/02 7:21am ET

Actavis PLC (NYSE:ACT)

226.98
Data as of Aug 29
 +0.39 / +0.17%
Today’s Change
131.56
Today|||52-Week Range
230.77
+35.11%
Year-to-Date

Today’s Trading

Previous close226.59
Today’s open227.02
Day’s range-- - --
Volume845,746
Average volume (3 months)2,337,332
Market cap$60.0B
Dividend yield--
Data as of 08/29/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.76%
Earnings growth (next 5 years)+18.86%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.11-0.26%
LLYEli Lilly and Co+0.45+0.71%
AGNAllergan Inc+1.57+0.97%
SHPGShire PLC-0.51-0.21%
Data as of 08/29/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$3.09
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts